» Articles » PMID: 10756051

Unusual Polymorphisms in Human Immunodeficiency Virus Type 1 Associated with Nonprogressive Infection

Overview
Journal J Virol
Date 2001 Feb 7
PMID 10756051
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

Factors accounting for long-term nonprogression may include infection with an attenuated strain of human immunodeficiency virus type 1 (HIV-1), genetic polymorphisms in the host, and virus-specific immune responses. In this study, we examined eight individuals with nonprogressing or slowly progressing HIV-1 infection, none of whom were homozygous for host-specific polymorphisms (CCR5-Delta32, CCR2-64I, and SDF-1-3'A) which have been associated with slower disease progression. HIV-1 was recovered from seven of the eight, and recovered virus was used for sequencing the full-length HIV-1 genome; full-length HIV-1 genome sequences from the eighth were determined following amplification of viral sequences directly from peripheral blood mononuclear cells (PBMC). Longitudinal studies of one individual with HIV-1 that consistently exhibited a slow/low growth phenotype revealed a single amino acid deletion in a conserved region of the gp41 transmembrane protein that was not seen in any of 131 envelope sequences in the Los Alamos HIV-1 sequence database. Genetic analysis also revealed that five of the eight individuals harbored HIV-1 with unusual 1- or 2-amino-acid deletions in the Gag sequence compared to subgroup B Gag consensus sequences. These deletions in Gag have either never been observed previously or are extremely rare in the database. Three individuals had deletions in Nef, and one had a 4-amino-acid insertion in Vpu. The unusual polymorphisms in Gag, Env, and Nef described here were also found in stored PBMC samples taken 3 to 11 years prior to, or in one case 4 years subsequent to, the time of sampling for the original sequencing. In all, seven of the eight individuals exhibited one or more unusual polymorphisms; a total of 13 unusual polymorphisms were documented in these seven individuals. These polymorphisms may have been present from the time of initial infection or may have appeared in response to immune surveillance or other selective pressures. Our results indicate that unusual, difficult-to-revert polymorphisms in HIV-1 can be found associated with slow progression or nonprogression in a majority of such cases.

Citing Articles

Comparison of the Biological Basis for Non-HIV Transmission to HIV-Exposed Seronegative Individuals, Disease Non-Progression in HIV Long-Term Non-Progressors and Elite Controllers.

Hokello J, Tyagi P, Dimri S, Sharma A, Tyagi M Viruses. 2023; 15(6).

PMID: 37376660 PMC: 10301403. DOI: 10.3390/v15061362.


Contribution of the HIV-1 Envelope Glycoprotein to AIDS Pathogenesis and Clinical Progression.

Valenzuela-Fernandez A, Cabrera-Rodriguez R, Casado C, Perez-Yanes S, Pernas M, Garcia-Luis J Biomedicines. 2022; 10(9).

PMID: 36140273 PMC: 9495913. DOI: 10.3390/biomedicines10092172.


Attenuated HIV-1 Nef But Not Vpu Function in a Cohort of Rwandan Long-Term Survivors.

Umviligihozo G, Mann J, Jin S, Mwimanzi F, Hsieh H, Sudderuddin H Front Virol. 2022; 2.

PMID: 35982753 PMC: 9383652. DOI: 10.3389/fviro.2022.917902.


Reduced CCR5 Expression and Immune Quiescence in Black South African HIV-1 Controllers.

Picton A, Paximadis M, Koor G, Bharuthram A, Shalekoff S, Lassauniere R Front Immunol. 2022; 12:781263.

PMID: 34987508 PMC: 8720782. DOI: 10.3389/fimmu.2021.781263.


Molecular genotypes of gag sequences in HIV-1 infected children treated with antiretroviral therapy in Vietnam.

Vu Phuong Dang L, Pham H, Dinh T, Vu P, Van Nguyen L, Le H Ther Adv Infect Dis. 2020; 7:2049936120958536.

PMID: 32994994 PMC: 7502858. DOI: 10.1177/2049936120958536.


References
1.
Gibbs J, Regier D, Desrosiers R . Construction and in vitro properties of HIV-1 mutants with deletions in "nonessential" genes. AIDS Res Hum Retroviruses. 1994; 10(4):343-50. DOI: 10.1089/aid.1994.10.343. View

2.
Greenough T, Brettler D, Somasundaran M, Panicali D, Sullivan J . Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss: evidence supporting a protective role for CTL in vivo. J Infect Dis. 1997; 176(1):118-25. DOI: 10.1086/514013. View

3.
Kirchhoff F, Greenough T, Brettler D, Sullivan J, Desrosiers R . Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med. 1995; 332(4):228-32. DOI: 10.1056/NEJM199501263320405. View

4.
Gibbs J, Lackner A, Lang S, Simon M, Sehgal P, Daniel M . Progression to AIDS in the absence of a gene for vpr or vpx. J Virol. 1995; 69(4):2378-83. PMC: 188910. DOI: 10.1128/JVI.69.4.2378-2383.1995. View

5.
Kondo E, Mammano F, Cohen E, Gottlinger H . The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles. J Virol. 1995; 69(5):2759-64. PMC: 188969. DOI: 10.1128/JVI.69.5.2759-2764.1995. View